Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-11

Clinical Trial Update: Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating calcium chloride to prevent blood loss during intrapartum cesarean delivery has completed with results posted (June 11, 2024…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium Chloride (Calcium chloride)

Snippet

Sponsor: Stanford University | Conditions: Uterine Atony, Uterine Atony With Hemorrhage | Phase 3 | Status: COMPLETED | Results posted: 2024-06-11